Intignus Biotech is a biotechnology company that is focused on discovering and developing diagnostic tests for rapid, low-cost, and early detection of human diseases. Their special focus area is maternal and child health care and the timely detection of pregnancy-related disorders. They are currently working on an early screening device for preeclampsia.
Intignus was founded by Vaishnavi Kulkarni, a NIDHI EIR Fellow at Venture Center.
MediAsha Technologies is a healthcare startup focusing on solving unmet needs and bringing forth novel medical devices. The company has developed its first product ‘InstaSplint’, a first-aid device that immobilizes a fractured limb until the person is taken to the hospital. The splint helps in providing rest to the injured area, preventing further displacement of bone fragments and thus protecting the underlying vessels and nerves from the fracture fragments. MediAsha is a recepient of BIRAC’s Biotechnology Ignition Grant among other awards.
MediAsha was founded in February 2018 by Mr. Mayur Sanas who is currently pursuing his PhD from the College of Engineering Pune.
Kozhnosys is a start-up involved in the development of biomedical devices with the aim of building cost-effective and easy to use medical diagnostic devices using cutting-edge technology. Currently they are developing a routine screening device for cancer. The company is working towards demonstrating proof of concept for a novel molecular-imprinted polymer coated quartz crystal microbalance sensor for rapid breath based routine screening for breast cancer, by identifying elevated concentration of volatile markers in exhaled breath.
Dzeal is developing indigenous innovations in the field of dentistry. The products and services that they are developing and intend to develop are:
(a) Rotary Endodontic file in basket form to be used in root canal treatment of teeth.
(b) GumCair: An innovative medical device that will use air/ gas to heal or to prevent the progression or recurrence of gum disease (periodontitis) after primary clinical cure
(c) Healer: A software that may be combined with hardware to help keep track of disease and prescriptions. The primary aim is to be able to register the incidence of disease pattern and the pattern of drug use geographically. The software can be particularly useful to government agencies in regulating the indiscriminate use of antibiotics and obtaining live data for monitoring the prevalence of disease in a particular area.
(d) Dental Services: DZeal also plans to providing evidence-based dental treatment at affordable rates. They are currently working from one location in Mumbai, and hope to expand their network in the near future.
Shapecrunch is aiming to reinvent custom foot products with 3D Printing & Shapecrunch‘s Mobile app. It makes 3D models of foot orthotics from photos of feet using computer vision & machine learning. The mobile app eliminates the need for a scanner for doctors and the 3D printing technology lowers the cost, thereby saving time, money, effort and providing consistent quality. The same technology can be used for making prosthetics and even custom footwear too. The technology is being used by 25 clinics in India. Shapecrunch is seed funded, and has been accepted for a SPARSH BIRAC grant.
Genrich Membranes Pvt. Ltd., a spin-off company based on proprietary technology from CSIR-National Chemical Laboratory, Pune, uses hollow fiber membrane technology to offer cost-effective solutions for O2 enriched sterile air for medical applications (oxygen therapy) for patients suffering from respiratory diseases (asthma, COPD, neonatal, etc.). The developed membrane-based oxygen enrichment unit elevates the amount of O2 in ambient air to only 35%, thus making it a more energy efficient process compared to existing technologies. Moreover, the current OEU is adaptable to diverse applications (rural health centers, hospitals, home care, ambulance, oxygen booths/spas, etc.). In addition, since there is no fouling, these membrane systems can be expected to have a long operational life with minimum maintenance. Genrich membranes has received Biotechnology Ignition Grant by DBT-BIRAC, GoI
Orthocrafts is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program. The start-up focuses on the development of high molecular weight polylactic acid based bioabsorbable implants. The company will eventually cater to the sports medicine market of India. Orthocrafts has received Biotechnology Ignition Grant by DBT-BIRAC, GoI
Module is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program. The start-up is developing affordable and innovative diagnostic devices for rapid microbial detection. The company will leverage the platform technology developed at CSIR-NCL Pune to develope quick, colorimetric, portable and reusable biosensor based on nanofibers for E.coli O157:H7 sensing and detection. The team has already demonstrated reversible thermal chromism and solvent chromism in nanofibers of PCDA/PHBV by doping ZnO nanoparticles and Color change by Biotin-Streptavidin interaction in solution phase. The company has received Biotechnology Ignition Grant by DBT-BIRAC, GoI. They have also been featured at various news media including Economic Times, Times of India and Pixr 8. Module is founded by two engineers Sachin Dubey and usman Khan both of them holding B.Tech and M.tech from University of Rajasthan, Jaipur.